Novo Nordisk may attempt to mitigate the impact from off-patent competition by protecting their share of Wegovy by enhancing weight-management services, or migrating patients from semaglutide to newer, patent-protected AOMs, including offering an oral version of semaglutide, effectively offering therapies with greater patient benefits
Our coverage of cagrilintide for weight loss , cagrilintide for men , cagrilintide dosing , CagriSema dosing , and the amylin receptor agonist mechanism provides the full picture
Breadless removes bread entirely and uses Swiss chard or collard greens instead
Semaglutide (marketed under brand names like Wegovy and Ozempic) and Tirzepatide (Mounjaro and Zepbound) are GLP-1 receptor agonists that help regulate appetite, insulin, and metabolism
Importantly, Wegovy is contraindicated in pregnancy and should be discontinued at least 2 months before a planned pregnancy